Terminologies de Santé (Publiées par l'ANS)
0.1.0 - ci-build
Terminologies de Santé (Publiées par l'ANS) - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Retired as of 2023-04-04 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="1.2.250.1.213.1.1.5.429"/>
<meta>
<versionId value="1"/>
<lastUpdated value="2024-12-19T05:06:27.821+00:00"/>
<profile
value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet 1.2.250.1.213.1.1.5.429</b></p><a name="1.2.250.1.213.1.1.5.429"> </a><a name="hc1.2.250.1.213.1.1.5.429"> </a><a name="1.2.250.1.213.1.1.5.429-fr-FR"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 1; Last updated: 2024-12-19 05:06:27+0000</p><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/R4/shareablevalueset.html">Shareable ValueSet</a></p></div><ul><li>Include these codes as defined in <code>1.3.6.1.4.1.19376.1.8.2.1</code><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>709</td><td>pT0: No evidence of primary tumor</td></tr><tr><td>710</td><td>pTis (DCIS): Ductal carcinoma in situ</td></tr><tr><td>711</td><td>pTis (LCIS): Lobular carcinoma in situ</td></tr><tr><td>712</td><td>pTis (Paget): Paget disease of the nipple not associated with invasive carcinoma and/or carcinoma in situ (DCIS and/or LCIS) in the underlying breast parenchyma</td></tr><tr><td>713</td><td>pT1: Tumor < =20 mm in greatest dimension</td></tr><tr><td>714</td><td>pT1mi: Tumor < =1 mm in greatest dimension (microinvasion)</td></tr><tr><td>715</td><td>pT1a: Tumor >1 mm but < = 5 mm in greatest dimension</td></tr><tr><td>716</td><td>pT1b: Tumor >5 mm but < = 10 mm in greatest dimension</td></tr><tr><td>717</td><td>pT1c: Tumor >10 mm but < = 20 mm in greatest dimension</td></tr><tr><td>718</td><td>pT2: Tumor >20 mm but < = 50 mm in greatest dimension</td></tr><tr><td>719</td><td>pT3: Tumor >50 mm in greatest dimension</td></tr><tr><td>720</td><td>pT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). Note: Invasion of the dermis alone does not qualify as pT4.</td></tr><tr><td>721</td><td>pT4a: Extension to chest wall, not including only pectoralis muscle adherence/invasion</td></tr><tr><td>722</td><td>pT4b: Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d’orange) of the skin which do not meet the criteria for inflammatory carcinoma</td></tr><tr><td>723</td><td>pT4c: Both T4a and T4b</td></tr><tr><td>724</td><td>pT4d: Inflammatory carcinoma</td></tr></table></li></ul></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod">
<valuePeriod>
<start value="2021-03-15T00:00:00+01:00"/>
</valuePeriod>
</extension>
<url
value="https://smt.esante.gouv.fr/fhir/ValueSet/1.2.250.1.213.1.1.5.429"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:1.2.250.1.213.1.1.5.429"/>
</identifier>
<version value="20230404000000"/>
<name value="JDV_Sein_pT_CISIS"/>
<title value="JDV_Sein_pT_CISIS"/>
<status value="retired"/>
<experimental value="false"/>
<date value="2023-04-04T00:00:00+01:00"/>
<publisher
value="Agence du Numérique en Santé(ANS) -2 - 10 Rue d'Oradour-sur-Glane, 75015 Paris"/>
<description value="JDV_Sein_pT_CISIS"/>
<compose>
<include>
<system value="1.3.6.1.4.1.19376.1.8.2.1"/>
<concept>
<code value="709"/>
<display value="pT0: No evidence of primary tumor"/>
</concept>
<concept>
<code value="710"/>
<display value="pTis (DCIS): Ductal carcinoma in situ"/>
</concept>
<concept>
<code value="711"/>
<display value="pTis (LCIS): Lobular carcinoma in situ"/>
</concept>
<concept>
<code value="712"/>
<display
value="pTis (Paget): Paget disease of the nipple not associated with invasive carcinoma and/or carcinoma in situ (DCIS and/or LCIS) in the underlying breast parenchyma"/>
</concept>
<concept>
<code value="713"/>
<display value="pT1: Tumor < =20 mm in greatest dimension"/>
</concept>
<concept>
<code value="714"/>
<display
value="pT1mi: Tumor < =1 mm in greatest dimension (microinvasion)"/>
</concept>
<concept>
<code value="715"/>
<display
value="pT1a: Tumor >1 mm but < = 5 mm in greatest dimension"/>
</concept>
<concept>
<code value="716"/>
<display
value="pT1b: Tumor >5 mm but < = 10 mm in greatest dimension"/>
</concept>
<concept>
<code value="717"/>
<display
value="pT1c: Tumor >10 mm but < = 20 mm in greatest dimension"/>
</concept>
<concept>
<code value="718"/>
<display
value="pT2: Tumor >20 mm but < = 50 mm in greatest dimension"/>
</concept>
<concept>
<code value="719"/>
<display value="pT3: Tumor >50 mm in greatest dimension"/>
</concept>
<concept>
<code value="720"/>
<display
value="pT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). Note: Invasion of the dermis alone does not qualify as pT4."/>
</concept>
<concept>
<code value="721"/>
<display
value="pT4a: Extension to chest wall, not including only pectoralis muscle adherence/invasion"/>
</concept>
<concept>
<code value="722"/>
<display
value="pT4b: Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d’orange) of the skin which do not meet the criteria for inflammatory carcinoma"/>
</concept>
<concept>
<code value="723"/>
<display value="pT4c: Both T4a and T4b"/>
</concept>
<concept>
<code value="724"/>
<display value="pT4d: Inflammatory carcinoma"/>
</concept>
</include>
</compose>
</ValueSet>